Abstract:Marine environments are underexplored terrains containing fungi that produce a diversity of natural products given unique environmental pressures and nutrients. While bacteria are commonly the most studied microorganism for natural products in the marine world, marine fungi are also abundant but remain an untapped source of bioactive metabolites. Given that their terrestrial counterparts have been a source of many blockbuster antitumor agents and anti-infectives, including camptothecin, the penicillins, and cyclosporin A, marine fungi also have the potential to produce new chemical scaffolds as leads to potential drugs. Fungi are more phylogenetically diverse than bacteria and have larger genomes that contain many silent biosynthetic gene clusters involved in making bioactive compounds. However, less than 5% of all known fungi have been cultivated under standard laboratory conditions. While the number of reported natural products from marine fungi is steadily increasing, their number is still significantly lower compared to those reported from their bacterial counterparts. Herein, we discuss many varied cytotoxic and anti-infective fungal metabolites isolated from extreme marine environments, including symbiotic associations as well as extreme pressures, temperatures, salinity, and light. We also discuss cultivation strategies that can be used to produce new bioactive metabolites or increase their production. This review presents a large number of reported structures though, at times, only a few of a large number of related structures are shown.

Progress on the bioactive secondary metabolites from marine fungi

Bioactive Metabolites From Marine Microorganisms

Natural bioactive compounds from marine fungi (2017–2020)

Advances in secondary metabolites of fungi isolated from the marine alga

A Brief Review of Bioactive Metabolites Derived from Deep-Sea Fungi

A review on studies of secondary metabolites from marine fungi

Secondary Metabolites from Coral-Associated Fungi: Source, Chemistry and Bioactivities

An Overview of the Mechanisms of Marine Fungi-Derived Anti-Inflammatory and Anti-Tumor Agents and Their Novel Role in Drug Targeting

An Update Review of Secondary Metabolites from Marine Fungi.

Secondary metabolites of marine-derived actinomycete microbes and their bioactivities

Origins, Structures, and Bioactivities of Secondary Metabolites from Marine-derived Penicillium Fungi.

Research progress on the secondary metabolites of marine actinomycetes and their antibacterial, antiviral and antitumor activities

Progress in the discovery of new bioactive substances from deep-sea associated fungi during 2020-2022

Progress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms

Novel Bioactive Natural Products from Marine-Derived Penicillium Fungi: A Review (2021–2023)

Marine Fungi-Derived Secondary Metabolites: Potential as Future Drugs for Health Care

Secondary Metabolites from Marine Micromonospora: Chemistry and Bioactivities

Advances in the Study of the Structures and Bioactivities of Metabolites Isolated from Mangrove-Derived Fungi in the South China Sea

Extremophilic Fungi from Marine Environments: Underexplored Sources of Antitumor, Anti-Infective and Other Biologically Active Agents

Deep-Sea-Derived Fungi as Valuable Producers of Cytotoxic Secondary Metabolites and Their Leads Potential

Advances in Studies of Antitumor Compounds from Marine Fungi